Inside the Medtronic recall. What should we make of it?
As most people involved in WeAreNotWaiting are aware, on June 27th, the FDA issued a warning about cybersecurity issues with older medtronic pumps. These happen […]
FDA
#Afrezza or How not to do Diabetes Pharma. Can @SanofiDiabetes shed a little more light? – Updated
***NOTE: This post has been updated following re-reading of the SEC documents relating to the Chang Yi LIang case due to mis-reading of the data*** […]
#wearenotwaiting – Disparity of access to Type 1 Diabetes treatments – Globalization? You are having a laugh.
All the time spent on looking at various aspects of Diabetes care during Diabetes Awareness Month made one thing very clear, which was massively accentuated […]